Hims & Hers CEO says FTC lawsuit misunderstands how the company works

Business

Hims & Hers CEO Andrew Dudum spoke to CNBC about the FTC's lawsuit against the company, compounded GLP-1 drugs and AI.

Read the original report.

Articles You May Like

Rivian third-quarter earnings beat estimates as software revenue, R2 deliveries rise
Treasury Department announces new Series I bond rate of 5.51% for the next six months
Social Security’s 2027 Increase Highlights A Bigger Retirement Challenge
Honda warns 50% Canada auto tariffs would be catastrophic for industry
Budget update: Canberra won’t promise savings as another rate rise looms

Leave a Reply

Your email address will not be published. Required fields are marked *